Dishman eyes European buy (Business Standard 4th Feb 2008) Dishman Pharmaceuticals & Chemicals is planning to acquire a company in Europe with a war chest of around Rs 200 crore. The Ahmedabad-based company, which manufactures APIs (active pharmaceutical ingredients), is eyeing inorganic growth in Europe and is in talks with a company there. “The acquisition, as and when it happens, will strengthen the company’s position in the European markets,” said a company official. Also on the anvil is the setting up of a new plant in China and fresh investments for its Gujarat-based plants. “We are looking at targets in Europe and the final decision may be taken in three to four months. We are scouting for companies that are less than Rs 200 crore in value,” Chief Financial Officer V V S Murthy said. The company has not appointed any merchant bankers for the proposed buy, preferring to hold direct talks. Besides looking to grow through the inorganic route, the company has embarked on an exp...
This is my investment scrapbook. My request to viewers would be to use their own judgment before taking call on any shares mentioned here. Moreover, although I always try to be accurate and correct , there is no guarantee of the accuracy and correctness of the information provided here. Viewers would be using information provided here at their own risk. I won't be liable for any loss whatsoever for transaction based on the information provided here.